Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
Jenkin
D
D
Doyle
J
J
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity; D002648:Child; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage; D009369:Neoplasms / Q000139:chemically induced; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011832:Radiation Injuries / Q000150:complications; D014750:Vincristine / Q000008:administration & dosage; D014777:Virus Diseases / Q000209:etiology
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone